A detailed history of Lpl Financial LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Lpl Financial LLC holds 65,856 shares of ROIV stock, worth $825,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,856
Previous 30,478 116.08%
Holding current value
$825,175
Previous $322,000 135.71%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.17 - $12.5 $359,794 - $442,225
35,378 Added 116.08%
65,856 $759,000
Q2 2024

Aug 07, 2024

SELL
$10.36 - $11.74 $83,522 - $94,647
-8,062 Reduced 20.92%
30,478 $322,000
Q1 2024

May 10, 2024

BUY
$9.87 - $11.8 $183,088 - $218,890
18,550 Added 92.8%
38,540 $406,000
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $76,090 - $105,146
9,080 Added 83.23%
19,990 $224,000
Q3 2023

Nov 13, 2023

BUY
$9.76 - $13.19 $106,481 - $143,902
10,910 New
10,910 $127,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.83B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.